Last reviewed · How we verify
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
The purpose of this protocol is to provide continued acess to immunosuppressive medications to subjects from the completed/closed trial ITN005CT (NIS01,NCT00014911). THIS PROTOCOL DOES NOT PROVIDE MEDICINES TO DIABETES PATIENTS WHO DID NOT PARTICIPATE IN ITN005CT.
Details
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| Status | NO_LONGER_AVAILABLE |
Conditions
- Diabetes Mellitus, Type 1
Interventions
- Sirolimus
- Tacrolimus
- Mycophenolate mofetil
- Mycophenolic acid
Countries
United States